OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert RHHV.../  DE000ME50YC3  /

Stuttgart
8/30/2024  5:53:53 PM Chg.- Bid10:00:34 PM Ask10:00:34 PM Underlying Strike price Expiration date Option type
249.44EUR - -
Bid Size: -		 -
Ask Size: -		 Roche Holding Ltd - - 9/27/2024 Call
GlobeNewswire 9/1 Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
TeleTrader 7/25 Europe lower premarket as earnings pour in
TeleTrader 7/25 Roche's H1 sales at 29.85 billion Swiss francs
GlobeNewswire 6/13 Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 5/27 Roche shuffles its executive committee
TeleTrader 5/16 Roche notes progress in obesity drug trial
TeleTrader 4/24 Roche's logs 14.4 billion Swiss francs in Q1 sales
TeleTrader 2/1 Roche's 2023 sales increase 1% to 58.7B Swiss francs
TeleTrader 12/4/2023 Roche to buy Carmot Therapeutics for $2.7B
TeleTrader 10/23/2023 Roche to buy Telavant for $7.1 billion
TeleTrader 7/27/2023 Roche's sales fall 8% ito 29.8B Swiss francs in H1
TeleTrader 4/26/2023 Roche posts sales of 15.3B Swiss francs in Q1
TeleTrader 2/2/2023 Roche's 2022 sales stable at 63.28B Swiss francs
TeleTrader 12/12/2022 Roche Pharmaceuticals CEO leaves the company
TeleTrader 10/18/2022 Roche's sales down 6% to 14.7B Swiss francs in Q3
TeleTrader 7/21/2022 Roche's H1 group sales up 5% to 32.3B Swiss francs
TeleTrader 4/25/2022 Roche's Q1 sales up 11% to $17.17 billion
TeleTrader 2/3/2022 Europe opens mixed with ECB's interest rates call in focus
TeleTrader 2/3/2022 Roche's 2021 sales up by 8% to 62.8B Swiss francs
TeleTrader 12/27/2021 Switzerland approves use of Roche COVID treatment
TeleTrader 11/4/2021 Novartis to sell stake in Roche for $20.7 billion
TeleTrader 9/9/2021 Roche acquires long-term biotech partner
TeleTrader 7/22/2021 Roche tops estimates with H1 sales at 30.71B Swiss francs
GlobeNewswire 7/12/2021 Atsena Therapeutics Appoints Jennifer Wellman to Board of Directors